Tilray easily_老虎社区_美港股上老虎

2021-03-19

Tilray easily

Better Pot Stock: Sundial Growers or Tilray?<blockquote>更好的盆栽股票：日晷种植者还是Tilray？</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":350951645,"tweetId":"350951645","gmtCreate":1616153282687,"gmtModify":1634526979629,"author":{"id":3567602190294873,"idStr":"3567602190294873","authorId":3567602190294873,"authorIdStr":"3567602190294873","name":"Kaka85","avatar":"https://static.tigerbbs.com/910cbde97dcc78d3d6264dbe2422fdad","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Tilray easily</body></html>","htmlText":"<html><head></head><body>Tilray easily</body></html>","text":"Tilray easily","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/350951645","repostId":1138846673,"repostType":4,"repost":{"id":"1138846673","kind":"news","pubTimestamp":1616152403,"share":"https://www.laohu8.com/m/news/1138846673?lang=zh_CN&edition=full","pubTime":"2021-03-19 19:13","market":"us","language":"en","title":"Better Pot Stock: Sundial Growers or Tilray?<blockquote>更好的盆栽股票：日晷种植者还是Tilray？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138846673","media":"Motley Fool","summary":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention i","content":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.<blockquote>以下是这两只热门大麻股票的比较情况。到目前为止，2021 年没有哪只大麻股票比日晷生长器（纳斯达克股票代码：SNDL）蒂尔雷（纳斯达克股票代码：TLRY）。考虑到两家公司的股价今年迄今已几乎上涨了两倍，这种关注是压倒性的积极。</blockquote>However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.<blockquote>然而，成为聚光灯下的兴奋感会很快消退。这两只大锅股票中哪一只是未来更好的选择？以下是日晷和蒂尔雷是如何相互对抗的。</blockquote>Growth<blockquote>增长</blockquote>Tilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.<blockquote>Tilray 第四季度收入同比增长 20.5%，达到 5660 万美元。该公司的国际医用大麻销售额飙升 191%，而其加拿大成人娱乐用大麻销售额飙升 49%。Tilray 唯一的美中不足是其大麻部门，该部门的收入下降了 18%。</blockquote>Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.<blockquote>Sundial 周三公布了第四季度业绩，其故事远不如 Tilray。该公司报告大麻净收入为1390万加元。虽然这比上一季度增长了 8%，但 Sundial 的收入同比下降了 5% 以上。</blockquote>Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.<blockquote>Sundial 和 Tilray 都有机会在加拿大市场发展，尤其是在该国大麻 2.0 衍生品市场继续增长势头的情况下。然而，Tilray肯定会有优势。</blockquote>Tilray's merger withAphria(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.<blockquote>Tilray 与阿弗里亚（纳斯达克股票代码：APHA）预计将于 2021 年第二季度关闭。合并后的公司将成为全球最大的大麻生产商。它还将在加拿大零售大麻市场占据领先的市场份额。</blockquote>The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.<blockquote>“新”Tilray也将成为欧洲医用大麻市场的顶级参与者，因为Aphria拥有一家主要的德国大麻批发商。Tilray 还在葡萄牙经营一家大型大麻生产设施。日晷目前在欧洲还没有业务。</blockquote>Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.<blockquote>Tilray和Aphria在美国也有业务，而Sundial没有。Aphria 收购了精酿啤酒制造商 Sweetwater Brewing，Tilray 拥有领先的大麻食品制造商 Manitoba Harvest。合并后的公司认为，如果联邦大麻改革打开进入利润丰厚的美国大麻市场的大门，这些业务将为其提供一个很好的起点。</blockquote>Financial position<blockquote>财务状况</blockquote>Sundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.<blockquote>Sundial 第四季度净亏损 6410 万加元。截至 2021 年 3 月 15 日，该公司调整后的息税折旧摊销前利润 (EBITDA) 亏损为 560 万加元，无限制现金为 7.1 亿加元。</blockquote>Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.<blockquote>即使在 Aphria 合并之前，Tilray 的财务状况也要强劲得多。虽然该公司第四季度净亏损为 300 万美元，但与去年同期的 2.198 亿美元净亏损相比有了巨大改善。截至2020年底，Tilray还产生了220万美元的正调整后EBITDA，并拥有1.897亿美元的现金。</blockquote>The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.<blockquote>一旦Aphria合并完成，Tilray的财务状况应该会有所改善。Aphria 已连续七个季度实现调整后 EBITDA 盈利能力增长。合并后的实体预计将在交易完成后两年内实现显著的协同效应。</blockquote>Valuation<blockquote>估值</blockquote>Tilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?<blockquote>Tilray 目前的市值约为 45 亿美元，而 Sundial 的市值接近 24 亿美元。但是Tilray的价值实际上是Sundial的近两倍吗？</blockquote>We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.<blockquote>我们不能使用基于收益的估值指标来比较这两只股票。然而，从市销率来看，Sundial 和 Tilray 似乎很接近。Sundial 目前的交易价格约为过去 12 个月销售额的 24 倍，而 Tilray 的市盈率接近 23 倍。</blockquote>However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.<blockquote>然而，重要的是要记住，Tilray的销售额继续逐年上升，而Sundial的销售额仍在逐年下降。这使得 Tilray 的估值比 Sundial 更具吸引力。</blockquote>Better pot stock?<blockquote>更好的锅汤？</blockquote>This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.<blockquote>这个决定并不难。Tilray 的增长速度比 Sundial 快，并且随着 Aphria 合并的进行，其未来的增长前景似乎更为强劲。它声称比 Sundial 更强大的财务状况，最重要的是，Tilray 的估值目前更具吸引力。从各方面来看，Tilray 似乎是比 Sundial 更好的大麻股票。</blockquote>However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.<blockquote>不过，我认为这两只股票都不是投资者的好选择。还有其他几只股票比 Sundial Growers 或 Tilray 更有能力从美国大麻市场的增长中获利，它们的估值更具吸引力。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Pot Stock: Sundial Growers or Tilray?<blockquote>更好的盆栽股票：日晷种植者还是Tilray？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Pot Stock: Sundial Growers or Tilray?<blockquote>更好的盆栽股票：日晷种植者还是Tilray？</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-03-19 19:13\n\n</h4>\n</header>\n<article>\nHere's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.<blockquote>以下是这两只热门大麻股票的比较情况。到目前为止，2021 年没有哪只大麻股票比日晷生长器（纳斯达克股票代码：SNDL）蒂尔雷（纳斯达克股票代码：TLRY）。考虑到两家公司的股价今年迄今已几乎上涨了两倍，这种关注是压倒性的积极。</blockquote>However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.<blockquote>然而，成为聚光灯下的兴奋感会很快消退。这两只大锅股票中哪一只是未来更好的选择？以下是日晷和蒂尔雷是如何相互对抗的。</blockquote>Growth<blockquote>增长</blockquote>Tilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.<blockquote>Tilray 第四季度收入同比增长 20.5%，达到 5660 万美元。该公司的国际医用大麻销售额飙升 191%，而其加拿大成人娱乐用大麻销售额飙升 49%。Tilray 唯一的美中不足是其大麻部门，该部门的收入下降了 18%。</blockquote>Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.<blockquote>Sundial 周三公布了第四季度业绩，其故事远不如 Tilray。该公司报告大麻净收入为1390万加元。虽然这比上一季度增长了 8%，但 Sundial 的收入同比下降了 5% 以上。</blockquote>Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.<blockquote>Sundial 和 Tilray 都有机会在加拿大市场发展，尤其是在该国大麻 2.0 衍生品市场继续增长势头的情况下。然而，Tilray肯定会有优势。</blockquote>Tilray's merger withAphria(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.<blockquote>Tilray 与阿弗里亚（纳斯达克股票代码：APHA）预计将于 2021 年第二季度关闭。合并后的公司将成为全球最大的大麻生产商。它还将在加拿大零售大麻市场占据领先的市场份额。</blockquote>The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.<blockquote>“新”Tilray也将成为欧洲医用大麻市场的顶级参与者，因为Aphria拥有一家主要的德国大麻批发商。Tilray 还在葡萄牙经营一家大型大麻生产设施。日晷目前在欧洲还没有业务。</blockquote>Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.<blockquote>Tilray和Aphria在美国也有业务，而Sundial没有。Aphria 收购了精酿啤酒制造商 Sweetwater Brewing，Tilray 拥有领先的大麻食品制造商 Manitoba Harvest。合并后的公司认为，如果联邦大麻改革打开进入利润丰厚的美国大麻市场的大门，这些业务将为其提供一个很好的起点。</blockquote>Financial position<blockquote>财务状况</blockquote>Sundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.<blockquote>Sundial 第四季度净亏损 6410 万加元。截至 2021 年 3 月 15 日，该公司调整后的息税折旧摊销前利润 (EBITDA) 亏损为 560 万加元，无限制现金为 7.1 亿加元。</blockquote>Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.<blockquote>即使在 Aphria 合并之前，Tilray 的财务状况也要强劲得多。虽然该公司第四季度净亏损为 300 万美元，但与去年同期的 2.198 亿美元净亏损相比有了巨大改善。截至2020年底，Tilray还产生了220万美元的正调整后EBITDA，并拥有1.897亿美元的现金。</blockquote>The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.<blockquote>一旦Aphria合并完成，Tilray的财务状况应该会有所改善。Aphria 已连续七个季度实现调整后 EBITDA 盈利能力增长。合并后的实体预计将在交易完成后两年内实现显著的协同效应。</blockquote>Valuation<blockquote>估值</blockquote>Tilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?<blockquote>Tilray 目前的市值约为 45 亿美元，而 Sundial 的市值接近 24 亿美元。但是Tilray的价值实际上是Sundial的近两倍吗？</blockquote>We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.<blockquote>我们不能使用基于收益的估值指标来比较这两只股票。然而，从市销率来看，Sundial 和 Tilray 似乎很接近。Sundial 目前的交易价格约为过去 12 个月销售额的 24 倍，而 Tilray 的市盈率接近 23 倍。</blockquote>However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.<blockquote>然而，重要的是要记住，Tilray的销售额继续逐年上升，而Sundial的销售额仍在逐年下降。这使得 Tilray 的估值比 Sundial 更具吸引力。</blockquote>Better pot stock?<blockquote>更好的锅汤？</blockquote>This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.<blockquote>这个决定并不难。Tilray 的增长速度比 Sundial 快，并且随着 Aphria 合并的进行，其未来的增长前景似乎更为强劲。它声称比 Sundial 更强大的财务状况，最重要的是，Tilray 的估值目前更具吸引力。从各方面来看，Tilray 似乎是比 Sundial 更好的大麻股票。</blockquote>However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.<blockquote>不过，我认为这两只股票都不是投资者的好选择。还有其他几只股票比 Sundial Growers 或 Tilray 更有能力从美国大麻市场的增长中获利，它们的估值更具吸引力。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/19/better-pot-stock-sundial-growers-or-tilray/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138846673","content_text":"Here's how these two hot marijuana stocks compare.No cannabis stocks have attracted more attention in 2021 so far thanSundial Growers(NASDAQ:SNDL)andTilray(NASDAQ:TLRY). That attention has been overwhelmingly positive, considering that the share prices for both companies have almost tripled year to date.However, the excitement of being in the limelight can fade quickly. Which of these two pot stocks is the better pick going forward? Here's how Sundial and Tilray stack up against each other.GrowthTilray's revenuejumped 20.5% year over year in the fourth quarterto $56.6 million. The company's international medical cannabis sales skyrocketed 191%, while its Canadian adult-use recreational marijuana sales soared 49%. The only fly in the ointment for Tilray was its hemp segment, which experienced an 18% revenue decline.Sundial announced its Q4 results on Wednesday, and its story wasn't nearly as good as Tilray's. The company reported net cannabis revenue of 13.9 million in Canadian dollars. While this reflected an 8% increase from the prior quarter, Sundial's revenue was down more than 5% year over year.Both Sundial and Tilray have opportunities to grow in the Canadian market, especially as the country's Cannabis 2.0 derivatives market continues to pick up momentum. However, Tilray definitely will have an advantage.Tilray's merger withAphria(NASDAQ:APHA)is expected to close in the second quarter of 2021. The combined company will rank as the biggest global cannabis producer based on revenue. It will also claim the leading market share in the Canadian retail marijuana market.The \"new\" Tilray will also be a top player in European medical cannabis markets because Aphria owns a major German cannabis wholesaler. Tilray also operates a large cannabis production facility in Portugal. Sundial doesn't have a presence in Europe at this point.Tilray and Aphria also have businesses in the U.S., while Sundial doesn't. Aphria acquired craft-beer maker Sweetwater Brewing, and Tilray owns leading hemp foods manufacturer Manitoba Harvest. The combined company thinks that these operations will give it a great launching pad should federal cannabis reform open the door to jump into the lucrative U.S. cannabis market.Financial positionSundial posted a net loss of CA$64.1 million in the fourth quarter. The company generated an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss of CA$5.6 million and had CA$710 million in unrestricted cash as of March 15, 2021.Tilray is in a much stronger financial position even before the Aphria merger. While the company recorded a Q4 net loss of $3 million, it was a huge improvement from the net loss of $219.8 million in the prior-year period. Tilray also generated positive adjusted EBITDA of $2.2 million and had $189.7 million in cash as of the end of 2020.The financial situation for Tilray should improve once the Aphria merger closes. Aphria has delivered seven consecutive quarters of increasing adjusted EBITDA profitability. The combined entity expects to realize significant synergies within the two years following the finalization of the transaction.ValuationTilray's market cap currently stands at around $4.5 billion, while Sundial's is close to $2.4 billion. But is Tilray actually worth nearly twice as much as Sundial?We can't use earnings-based valuation metrics to compare the two stocks. However, Sundial and Tilray appear to be close using price-to-sales (P/S) ratios. Sundial currently trades at around 24 times trailing-12-month sales, while Tilray trades at a P/S multiple of nearly 23.However, it's important to remember that Tilray's sales continue to rise year over year while Sundial's are still declining year over year. This makes Tilray's valuation more attractive compared to Sundial.Better pot stock?This decision isn't difficult. Tilray is growing faster than Sundial and seems to have stronger growth prospects going forward with the Aphria merger on the way. It claims a stronger financial position than Sundial and, to top things off, Tilray's valuation is slightly more attractive right now. On all counts, Tilray appears to be the better pot stock than Sundial.However, I don't think that either of these stocks is a great choice for investors. There are several other stocks that are in a better position to profit from the U.S. cannabis market growth that are more attractively valued than either Sundial Growers or Tilray.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":941,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TLRY"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/350951645"}